Correlation Between SeqLL and Dermata Therapeutics
Can any of the company-specific risk be diversified away by investing in both SeqLL and Dermata Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining SeqLL and Dermata Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between SeqLL Inc and Dermata Therapeutics, you can compare the effects of market volatilities on SeqLL and Dermata Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in SeqLL with a short position of Dermata Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of SeqLL and Dermata Therapeutics.
Diversification Opportunities for SeqLL and Dermata Therapeutics
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between SeqLL and Dermata is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding SeqLL Inc and Dermata Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Dermata Therapeutics and SeqLL is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on SeqLL Inc are associated (or correlated) with Dermata Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Dermata Therapeutics has no effect on the direction of SeqLL i.e., SeqLL and Dermata Therapeutics go up and down completely randomly.
Pair Corralation between SeqLL and Dermata Therapeutics
If you would invest 134.00 in Dermata Therapeutics on December 28, 2024 and sell it today you would lose (8.00) from holding Dermata Therapeutics or give up 5.97% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Flat |
Strength | Insignificant |
Accuracy | 0.0% |
Values | Daily Returns |
SeqLL Inc vs. Dermata Therapeutics
Performance |
Timeline |
SeqLL Inc |
Risk-Adjusted Performance
Very Weak
Weak | Strong |
Dermata Therapeutics |
SeqLL and Dermata Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with SeqLL and Dermata Therapeutics
The main advantage of trading using opposite SeqLL and Dermata Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if SeqLL position performs unexpectedly, Dermata Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Dermata Therapeutics will offset losses from the drop in Dermata Therapeutics' long position.SeqLL vs. Agilent Technologies | SeqLL vs. iSpecimen | SeqLL vs. Intelligent Bio Solutions | SeqLL vs. bioAffinity Technologies, |
Dermata Therapeutics vs. Zura Bio Limited | Dermata Therapeutics vs. Phio Pharmaceuticals Corp | Dermata Therapeutics vs. Sonnet Biotherapeutics Holdings | Dermata Therapeutics vs. 180 Life Sciences |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.
Other Complementary Tools
Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
Stocks Directory Find actively traded stocks across global markets |